首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 心血管設備 > 全球心臟缺陷修補設備市場:2009年
產業/市場分類
醫療設備 (3974)
內視鏡檢查設備 (113)
分子呈像/呈影劑 (29)
心血管設備 (244)
可拋式醫學設備 (83)
核子醫學 (75)
病患監測 (343)
眼科設備 (100)
傷口護理 (87)
超音波 (49)
齒科設備 (172)
導管 (198)
整形外科 (329)
醫學影像診斷 (399)
體外診斷設備 (387)
CT/MRI/X光 (142)
e保健 (309)
市場調查報告書

全球心臟缺陷修補設備市場:2009年

Global Markets for Heart Defect Closure Devices 2009

出版商 Millennium Research Group
出版日期 2008年11月 商品編碼 77984
內容資訊 英文  
價格
US $ 4197 PDF by E-mail (Single user license)
US $ 6300 PDF by E-mail (Corporate license)


全球心臟缺陷修補設備市場:2009年 是由出版商Millennium Research Group在2008年11月所出版的。 這份英文市場調查報告書價格從美金4197起跳。

簡介

全球心臟缺陷修補設備市場在2008年的規模超過1億1,000萬美元。

本報告書內容包括:全球心臟缺陷修補設備市場概要、美國、歐洲、日本各國市場概要及分析、競爭動向等。內容綱要摘記如下:

實施概要

方法論

第1章 全球心臟缺陷修補設備市場

  • 市場概要
  • 症狀概要
  • 市場分析
    • 主要事件及前提條件
    • 處置
      • 心房中隔缺損修補
      • 開放性卵圓孔修補
      • 開放性動脈導管修補
      • 心室中隔缺損修補
    • 開放性卵圓孔隨機控管醫療實驗
    • 開放性卵圓孔修補相關醫生的回饋
    • 市場預測
      • 心房中隔缺損修補設備市場
      • 開放性卵圓孔修補設備市場
      • 開放性動脈導管修補設備市場
      • 心室中隔缺損修補設備市場
    • 促進及抑制市場發展因素
  • 競爭分析

第2章 美國心臟缺陷修補設備市場

  • 市場概要
  • 市場分析
    • 主要事件及前提條件
    • 處置
      • 心房中隔缺損修補
      • 開放性卵圓孔修補
      • 開放性動脈導管修補
      • 心室中隔缺損修補
    • 市場預測
      • 心房中隔缺損修補設備市場
      • 開放性卵圓孔修補設備市場
      • 開放性動脈導管修補設備市場
      • 心室中隔缺損修補設備市場
    • 促進及抑制市場發展因素
  • 競爭分析

第3章 歐洲心臟缺陷修補設備市場

  • 市場概要
  • 市場分析
    • 主要事件及前提條件
    • 處置
      • 心房中隔缺損修補
      • 開放性卵圓孔修補
      • 開放性動脈導管修補
      • 心室中隔缺損修補
    • 市場預測
      • 心房中隔缺損修補設備市場
      • 開放性卵圓孔修補設備市場
      • 開放性動脈導管修補設備市場
      • 心室中隔缺損修補設備市場
    • 促進及抑制市場發展因素
  • 競爭分析

第4章 日本心臟缺陷修補設備市場

  • 市場概要
  • 市場分析
    • 主要事件及前提條件
    • 處置
    • 市場預測
    • 促進及抑制市場發展因素
  • 競爭分析

附錄

目錄

Abstract

The global heart defect closure device market - comprising sales of heart defect closure devices for atrial septal defects (ASDs), patent foramen ovales (PFOs), patent ductus arteriosi (PDAs), and ventricular septal defects (VSDs) in the US, Europe (France, Germany, Italy, and the UK), and Japan - was valued just over $110 million in 2008.

Research Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

  • Government Sources:
    • Securities and Exchange Commission filings
    • Food and Drug Administration and patent filings
    • National Center for Health Statistics data
  • Heart Defect Closure Device Companies:
    • Annual reports, product brochures, corporate profiles, etc.
  • Internal Databases and Reports:
    • Previous reports on similar/related sources
  • General Internet Searches, Medical Literature, and Newspaper/Magazine Searches:
    • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various heart defect closure device market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross - check the views of various experts against each other and reach positions of consensus on issues and market numbers.

In addition, a sample of key physician opinion leaders is also surveyed over the telephone. Physicians are asked to comment on various issues/trends regarding PFO closure, both in their own practice and in the overall market. The responses provided are then used to strengthen or augment the assumptions and hypotheses developed during the primary research phase.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross - checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL HEART DEFECT CLOSURE DEVICE MARKET

  • 1.1 Market Overview
  • 1.2 Condition Overview
    • 1.2.1 Atrial Septal Defect
    • 1.2.2 Patent Foramen Ovale
    • 1.2.3 Patent Ductus Arteriosus
    • 1.2.4 Ventricular Septal Defect
  • 1.3 Market Analysis
    • 1.3.1 Major Events and Assumptions
    • 1.3.2 Procedures
      • 1.3.2.1 Atrial Septal Defect Closure Device Procedures
      • 1.3.2.2 Patent Foramen Ovale Closure Device Procedures
      • 1.3.2.3 Patent Ductus Arteriosus Closure Procedures
      • 1.3.2.4 Ventricular Septal Defect Closure Device Procedures
    • 1.3.3 Patent Foramen Ovale Randomized Control Trial Review
      • 1.3.3.1 Trial Summaries for Cryptogenic Strokes and Transient Ischemic Attack Indications
      • 1.3.3.2 Trial Summaries for Migraine Indications
        • Completed Trials for Migraine Indications
        • Ongoing Trials for Migraine Indications
    • 1.3.4 Physician Feedback Regarding Patent Foramen Ovale Closure
    • 1.3.5 Market Forecast
      • 1.3.5.1 Atrial Septal Defect Closure Device Market
      • 1.3.5.2 Patent Foramen Ovale Closure Device Market
      • 1.3.5.3 Patent Ductus Arteriosus Closure Device Market
      • 1.3.5.4 Ventricular Septal Defect Closure Device Market
    • 1.3.6 Market Drivers and Limiters
      • 1.3.6.1 Market Drivers
      • 1.3.6.2 Market Limiters
  • 1.4 Competitive Analysis
    • 1.4.1 Competitive Landscape
    • 1.4.2 Emerging Competitors

2.0 US HEART DEFECT CLOSURE DEVICE MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Major Events and Assumptions
    • 2.2.2 Procedures
      • 2.2.2.1 Atrial Septal Defect Closure Device Procedures
      • 2.2.2.2 Patent Foramen Ovale Closure Device Procedures
        • Physician Feedback Regarding Patent Foramen Ovale Closure
      • 2.2.2.3 Patent Ductus Arteriosus Closure Device Procedures
      • 2.2.2.4 Ventricular Septal Defect Closure Device Procedures
    • 2.2.3 Market Forecast
      • 2.2.3.1 Atrial Septal Defect Closure Device Market
      • 2.2.3.2 Patent Foramen Ovale Closure Device Market
      • 2.2.3.3 Patent Ductus Arteriosus Closure Device Market
      • 2.2.3.4 Ventricle Septal Defect Closure Device Market
    • 2.2.4 Market Drivers and Limiters
  • 2.3 Competitive Analysis

3.0 EUROPEAN HEART DEFECT CLOSURE DEVICE MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Major Events and Assumptions
    • 3.2.2 Procedures
      • 3.2.2.1 Atrial Septal Defect Closure Device Procedures
      • 3.2.2.2 Patent Foramen Ovale Closure Device Procedures
        • Physician Feedback Regarding Patent Foramen Ovale Closure
      • 3.2.2.3 Patent Ductus Arteriosus Closure Device Procedures
      • 3.2.2.4 Ventricular Septal Defect Closure Device Procedures
    • 3.2.3 Market Forecast
      • 3.2.3.1 Atrial Septal Defect Closure Device Market
      • 3.2.3.2 Patent Foramen Ovale Closure Device Market
      • 3.2.3.3 Patent Ductus Arteriosus Closure Device Market
      • 3.2.3.4 Ventricle Septal Defect Closure Device Market
    • 3.2.4 Market Drivers and Limiters
  • 3.3 Competitive Analysis

4.0 JAPANESE HEART DEFECT CLOSURE DEVICE MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Major Events and Assumptions
    • 4.2.2 Procedures
    • 4.2.3 Market Forecast
    • 4.2.4 Market Drivers and Limiters
  • 4.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

  • Exhibit 1: Heart Defect Closure Device Market, Global (US$), 2007 - 2013
  • Exhibit 2: PFO Closure Device Procedures, by Device Type, US, 2007 - 2013
  • Exhibit 3: Heart Defect Closure Device Market, by Country, Europe, 2007 - 2013
  • Exhibit 4: Heart Defect Closure Device Market, by Indication, Japan, (US$), 2007 - 2013
  • Exhibit 5: Leading Competitors in the Global Heart Defect Closure Device Market,2008

METHODOLOGY

  • Exhibit 6: Currency Exchange Rates, 2008

CHAPTER 1: GLOBAL HEART DEFECT CLOSURE DEVICE MARKET

  • Exhibit 7: Heart Defect Closure Device Market, Global (US$), 2007 - 2013
  • Exhibit 8: Transcatheter Heart Defect Closure Procedures, by Region, Global, 2007 - 2013
  • Exhibit 9: Transcatheter Heart Defect Closure Procedures, by Indication, Global, 2007 - 2013
  • Exhibit 10: Transcatheter Heart Defect Closure Procedures, by Indication and Region, 2007 - 2013
  • Exhibit 11: Transcatheter Heart Defect Closure Procedure Growth, by Indication and Region, 2008 - 2013
  • Exhibit 12: CLOSE Clinical Trial Summary, 2008
  • Exhibit 13: CLOSURE I Clinical Trial Summary, 2008
  • Exhibit 14: PC-Trial Summary, 2008
  • Exhibit 15: REDUCE Clinical Trial Summary, 2008
  • Exhibit 16: RESPECT Clinical Trial Summary, 2008
  • Exhibit 17: MIST I Clinical Trial Summary, 2008
  • Exhibit 18: PREMIUM Clinical Trial Summary, 2008
  • Exhibit 19: PRIMA Clinical Trial Summary, 2008
  • Exhibit 20: Heart Defect Closure Device Market, by Region, Global (US$), 2007 - 2013
  • Exhibit 21: Heart Defect Closure Device Market, by Indication, Global (US$), 2007 - 2013
  • Exhibit 22: Heart Closure Device Market, by Indication and Region, Global (US$), 2007 - 2013
  • Exhibit 23: Heart Defect Closure Device Market Growth, by Indication and Region, 2008 - 2013
  • Exhibit 24: Drivers and Limiters of the Heart Defect Closure Device Market, Global
  • Exhibit 25: Key Facts in the Competitive Landscape of the Heart Defect Closure Device Market, Country, 2008
  • Exhibit 26: Leading Competitors in the Heart Defect Closure Device Market, as a % of Total, Global, 2008
  • Exhibit 27: Leading Competitors in the Heart Defect Closure Device Market, by Segment, as a % of Total, Global, 2008
  • Exhibit 28: Leading Competitors in the Heart Defect Closure Device Market, by Region, as a % of Total, Global, 2008

CHAPTER 2: US HEART DEFECT CLOSURE DEVICE MARKET

  • Exhibit 29: Heart Defect Closure Device Market, US (US$), 2007 - 2013
  • Exhibit 30: Transcatheter Heart Defect Closure Procedures, by Indication, US, 2007 - 2013 (Graphical Format)
  • Exhibit 31: Transcatheter Heart Defect Closure Procedures, by Indication, US, 2007 - 2013 (Tabular Format)
  • Exhibit 32: PFO Closure Device Procedures, by Indication, US, 2007 - 2013
  • Exhibit 33: PFO Closure Device Procedures, by Device Type, US, 2007 - 2013
  • Exhibit 34: PDA Closure Procedures, by Type, US, 2007 - 2013
  • Exhibit 35: Heart Defect Closure Device Market, by Indication, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 36: Heart Defect Closure Device Market, by Indication, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 37: Heart Defect Closure Device Market Growth, by Indication, US, 2008 - 2013
  • Exhibit 38: Heart Defect Closure Device Market, by Indication, as a % of Total, US, 2007 - 2013
  • Exhibit 39: ASD Closure Device Units, by Indication, US, 2007 - 2013 (Graphical Format)
  • Exhibit 40: ASD Closure Device Units, by Indication, US, 2007 - 2013 (Tabular Format)
  • Exhibit 41: Drivers of the Heart Defect Closure Device Market, US
  • Exhibit 42: Limiters of the Heart Defect Closure Device Market, US
  • Exhibit 43: Leading Competitors in the Heart Defect Closure Device Market, as a % of Total, US, 2007
  • Exhibit 44: Leading Competitors in the Heart Defect Closure Device Market, by Indication, as a % of Total, US, 2007

CHAPTER 3: EUROPEAN HEART DEFECT CLOSURE DEVICE MARKET

  • Exhibit 45: Heart Defect Closure Device Market, Europe (US$), 2007 - 2013
  • Exhibit 46: Transcatheter Heart Defect Closure Procedures, by Country, Europe, 2007 - 2013
  • Exhibit 47: Transcatheter Heart Defect Closure Procedures, by Indication, Europe, 2007 - 2013
  • Exhibit 48: Transcatheter Heart Defect Closure Procedures, by Indication and Country, Europe, 2007 - 2013
  • Exhibit 49: Transcatheter Heart Defect Closure Procedures, by Indication and Country, Europe, 2007 - 2013 (Continued)
  • Exhibit 50: Transcatheter Heart Defect Closure Procedure Growth, by Indication and Country, Europe, 2008 - 2013
  • Exhibit 51: Transcatheter Heart Defect Closure Procedure Growth, by Indication and Country, Europe, 2008 - 2013 (Continued)
  • Exhibit 52: PDA Closure Procedures, by Type and Country, Europe, 2007 - 2013
  • Exhibit 53: PDA Closure Procedure Growth, by Type and Country, Europe, 2008 - 2013
  • Exhibit 54: PDA Closure Procedure, by Country and Type, as a % of total, Europe, 2007 - 2013
  • Exhibit 55: Heart Defect Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 56: Heart Defect Closure Device Market, by Indication, Europe (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 57: Heart Defect Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 58: Heart Defect Closure Device Market, by Country, Europe (€ and £), 2007 - 2013
  • Exhibit 59: Heart Defect Closure Device Market Growth, by Country, Europe, 2008 - 2013
  • Exhibit 60: Heart Defect Closure Device Market, by Indication, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 61: Heart Defect Closure Device Market, by Indication, Europe (€ and £), 2007 - 2013
  • Exhibit 62: Heart Defect Closure Device Market Growth, by Indication, Europe, 2008 - 2013
  • Exhibit 63: ASD Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 64: ASD Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 65: ASD Closure Device Market, by Country, Europe, (€ and £), 2007 - 2013
  • Exhibit 66: ASD Closure Device Market Growth, by Country, Europe, 2008 - 2013
  • Exhibit 67: PFO Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 68: PFO Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 69: PFO Closure Device Market, by Country, Europe (€ and £), 2007 - 2013
  • Exhibit 70: PFO Closure Device Market Growth, by Country, Europe, 2008 - 2013
  • Exhibit 71: PDA Closure Device Market, by Country, Europe, (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 72: PDA Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 73: PDA Closure Device Market, by Country, Europe (€ and £), 2007 - 2013
  • Exhibit 74: PDA Closure Device Market Growth, by Country, Europe, 2008 - 2013
  • Exhibit 75: VSD Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 76: VSD Closure Device Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 77: VSD Closure Device Market, by Country, Europe, (€ and £), 2007 - 2013
  • Exhibit 78: VSD Closure Device Market Growth, by Country, Europe, 2008 - 2013
  • Exhibit 79: Drivers of the Heart Defect Closure Device Market, Europe
  • Exhibit 80: Limiters of the Heart Defect Closure Device Market, Europe
  • Exhibit 81: Leading Competitors in the Heart Defect Closure Device Market, as a % of Total, Europe, 2008
  • Exhibit 82: Leading Competitors in the Heart Defect Closure Device Market, by Country, as a % of Total, Europe, 2008
  • Exhibit 83: Leading Competitors in the Heart Defect Closure Device Market, by Indication, as a % of Total, Europe, 2007

CHAPTER 4: JAPANESE HEART DEFECT CLOSURE DEVICE MARKET

  • Exhibit 84: Heart Defect Closure Device Market, Japan (US$), 2007 - 2013
  • Exhibit 85: Transcatheter Heart Defect Closure Procedures, by Indication, Japan, 2007 - 2013 (Graphical Format)
  • Exhibit 86: Transcatheter Heart Defect Closure Procedures, by Indication, Japan, 2007 - 2013 (Graphical Format)
  • Exhibit 87: PDA Closure Procedures, by Type, Japan, 2007 - 2013
  • Exhibit 88: Heart Defect Closure Device Market, by Indication, Japan (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 89: Heart Defect Closure Device Market, by Indication, Japan (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 90: Heart Defect Closure Device Market, by Indication, Japan (¥), 2007 - 2013
  • Exhibit 91: Heart Defect Closure Device Market Growth, by Indication, Japan, 2008 - 2013
  • Exhibit 92: Heart Defect Closure Device Market, by Indication, as a % of Total, Japan, 2007 - 2013
  • Exhibit 93: Drivers of the Heart Defect Closure Device Market, Japan
  • Exhibit 94: Limiters of the Heart Defect Closure Device Market, Japan

APPENDIX B: SUPPLEMENTAL EXHIBITS

  • Exhibit 95: Heart Defect Closure Device Market, Global (US$), 2007 - 2013 (Detailed Format)
  • Exhibit 96: PFO Closure Device Procedures, by Device Type, US, 2007 - 2013 (Detailed Format)
  • Exhibit 97: Heart Defect Closure Device Market, by Country, Europe, 2007 - 2013 (Detailed Format)
  • Exhibit 98: Heart Defect Closure Device Market, by Indication, Japan, (US$), 2007 - 2013 (Detailed Format)
Back to Top